Provider of therapeutic services for cancer. The company specializes in the development of oncology antibodies for the treatment of cancer.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 30-Oct-2015 | $64.6M | 000.00 | Completed | Generating Revenue | |
1. Early Stage VC | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hans Van Eenennaam Ph.D | Co-Founder & Chief Operational Officer | ||
Andrea Elsas Ph.D | Co-Founder & Chief Scientific Officer |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Agri Food Health Innovation Centre | Venture Capital | Minority | 000 0000 | 000000 0 | |
Brabant Life Sciences Seed Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
Brabantse Ontwikkelings Maatschappij | Venture Capital | Minority | 000 0000 | 000000 0 |